In vitro release of heparin from silica xerogels

Biomaterials

Volumn 22, Issue 15, 2001, Pages 2163-2170

  Ahola, Manja S ^a,c   Säilynoja, Eija S ^b   Raitavuo, Mari H ^a   Vaahtio, Minna M ^b   Salonen, Jukka I ^b   Yli Urpo, Antti U O ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Turku Centre for Biomaterials   (Finland)

^c Oy Leiras Finland Ab   (Finland)

Author keywords

Controlled release; Heparin; Silica xerogel; Sol gel

Indexed keywords

CATALYSTS; CHEMICAL MODIFICATION; DISSOLUTION; MOISTURE; POLYCONDENSATION; SOL-GELS;

MEDICAL THROMBOSIS;

SILICA GEL;

ANTICOAGULANT AGENT; DRUG CARRIER; HEPARIN; SILICA XEROGEL; SILICATE; UNCLASSIFIED DRUG;

ARTICLE; CATALYST; CHEMICAL MODIFICATION; CHEMICAL PARAMETERS; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; DISSOLUTION; DRUG ACTIVITY; DRUG DEGRADATION; GEL; HUMAN; IN VITRO STUDY; MOISTURE; POLYMERIZATION; PRECURSOR; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOSIS;

BIOCOMPATIBLE MATERIALS; CATALYSIS; GELS; HEPARIN; MODELS, CHEMICAL; PROTEIN BINDING; SILICON; SOLUBILITY; TIME FACTORS;

EID: 0035424895     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00407-5     Document Type: Article

References (31)

1. In vitro evaluation of sustained drug release from biodegradable elastomer
2. Poly(orthoester) matrices for controlled release of the antitumour agent 5-fluorouracil
3. Biodegradable polyesters for controlled release of trypanocidal drugs: In vitro and in vivo studies
4. In vitro release of trypanocidal drugs from biodegradable implants based on poly(epsilon-caprolactone) and poly(D,L-lactide)
5. Perivascular delivery of heparin for the reduction of smooth muscle cell proliferation after endothelial injury
6. Mechanism of drug release from poly(L-lactic acid) matrix containing acidic or neutral drugs
7. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation
8. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix
9. Capronor - A biodegradable delivery system for levonorgestrel
10. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
11. In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier
12. Effect of processing parameters on the structure of silica xerogel matrix and on the release rate of toremifene citrate and silica
13. Silica xerogel carrier material for controlled release of toremifene citrate
14. Sol-gel carrier systems for controlled drug delivery
15. Sol-gel processed sintered silica xerogel as a carrier in controlled drug delivery
16. Diffusion of steroids in porous sol-gel glass: Application in slow drug delivery
17. Tissue reactions to controlled release silica xerogel carriers
18. Silica xerogel as an implantable carrier for controlled drug delivery - Evaluation of drug distribution and tissue effects after implantation
19. Further characterisation of the antithrombin binding sequence in heparin
20. New methods for surface modification and covalent attachment of heparin
21. Encapsulation of proteins in transparent porous silicate glasses prepared by the sol-gel method
22. Colorimetric method for the assay of heparin content in immobilized heparin preparations
23. Evaluation of blood compatibility of PEO grafted and heparin immobilised polyurethanes
24. Tailored porous materials
25. Effects of dimethyldiethoxysilane addition on tetraethylorthosilicate sol-gel process
26. Ultramicroscopic pore size and porosity of xerogels for controlled release of biological molecules